MedTrace Logo

Testosterone MD-Lotion Residual Washing Study

NCT00996151 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-03-02

No results posted yet for this study

Summary

The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.

Conditions

  • Hypergonadism

Interventions

DRUG

Testosterone MD-Lotion

Single dose Testosterone MD-Lotion 2%

Sponsors & Collaborators

  • Acrux DDS Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Tina Soulis, PhD · Acrux Pharma Pty Ltd

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996151 on ClinicalTrials.gov